COMPANY PROFILE

Kryptos Biotechnologies

Explore full profile

Aims to help scientists and clinicians to identify biological insights at a single-cell level

Seoul, South KoreaFounded 2017Biotech & Life Sciences

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Kryptos Biotechnologies

Kryptos Biotechnologies is a pioneering biotechnology startup specializing in advanced life science tools. The company operates in the single-cell analysis market, providing cutting-edge photonic PCR technology that offers precise temperature control, localized heating, and ultrafast thermalcycling. This technology is crucial for biological and clinical research, enabling scientists and clinicians to gain accurate biological insights at a single-cell level. Kryptos Biotechnologies serves researchers and healthcare professionals who require high-precision genomic analysis tools. The business model revolves around the development and sale of specialized equipment and technology solutions, generating revenue through direct sales and potential licensing agreements. The company's core technology, photothermal heating using optical thin film and LED, sets it apart in the market by efficiently converting light to heat, thus enhancing the accuracy and speed of genomic analysis.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Seoul, South Korea
Employees: 7
Open positions: None listed
Dealroom signal: 61.9/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Mar 2024	$10M	$40M	OSANG Healthcare	↗
CONVERTIBLEEquity / VC	Dec 2021	$6.5M	—	Undisclosed	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Kryptos Biotechnologies website traffic

Latest recorded traffic for Kryptos Biotechnologies is 910 monthly website visits, down 46.5% over the last three months. Kryptos Biotechnologies's team declined 12.5% over the past year.

Latest monthly visits910 3-month web change-46.5% 1-year team growth-12.5%

Monthly website visitsApr 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
DTDraig TherapeuticsTargeted neuromodulators for major neuropsychiatric disorders treatment	Cardiff, United Kingdom	Operational	44	$217M	$700M
XBXanadu BioPioneering cystic fibrosis treatment through small molecules and gene editing	Lower Merion Township, United States	Operational
STSolve TherapeuticsTargeted cancer therapies enhancing safety and precision	San Diego, United States	Operational
3535PharmaAdvancing therapeutic biologics to treat cardiopulmonary and metabolic diseases	Montreal, Canada	Acquired
AVAviadoBioPrecision gene therapies for neurodegenerative disorders	London, United Kingdom	Operational
TTTeitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases	Aarhus, Denmark	Operational
BIBioCaptivaNovel liquid biopsy device for cancer diagnostics	St Andrews, United Kingdom	Operational
MBMICA BiosystemsBiomagnetic technology for remote-controlled regenerative medicine applications	Solihull, United Kingdom	Operational